Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01815437 · ClinicalTrials.gov registry record · NA

Evaluating Vitamin D Content in Mushrooms

A NA study, sponsored by Boston University.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01815437: Completed NA study, sponsored by Boston University.

NCT01815437 is a NA study that has completed, run by Boston University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01815437, a NA study, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

This study will evaluate how much vitamin D is present in a mushroom supplement. This supplement contains an extract from mushrooms that have been exposed to sunlight. The mushroom supplement will be compared to non-commercially available vitamin D supplements produced in a Goo Manufacturing Practices (GMP)-licensed facility.

Primary Outcome

The primary outcome of this study is to examine changes in total 25(OH)D levels after ingestion of a vitamin D2 mushroom supplement manufactured by Monterey Mushrooms, Inc. compared to crystalline vitamin D2 from Nature's Life or vitamin D3 manufactured by Whole Health, Inc.

Interventions

  • DIETARY_SUPPLEMENT Cholecalciferol
  • DIETARY_SUPPLEMENT Mushroom Extract
  • DIETARY_SUPPLEMENT Mushroom Vitamin D2
  • DIETARY_SUPPLEMENT Vitamin D2 - Ergocalciferol

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2012-01
Est. Completion 2013-06
Phase NA
Boston University

185 total trials

What the finished NCT01815437 record still lists

NCT01815437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 4 interventions - of which Cholecalciferol is the first listed.

NCT01815437 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01815437 about?

NCT01815437 is a clinical study titled "Evaluating Vitamin D Content in Mushrooms". This study will evaluate how much vitamin D is present in a mushroom supplement. This supplement contains an extract from mushrooms that have been exposed to sunlight. The mushroom supplement will be compared to non-commercially available vitamin D supplements produced in a Goo Manufacturing Practic...

What is the current status of trial NCT01815437?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2012-01. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01815437?

The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Mushroom Extract (DIETARY_SUPPLEMENT), Mushroom Vitamin D2 (DIETARY_SUPPLEMENT), Vitamin D2 - Ergocalciferol (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01815437?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01815437's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01815437, the US trial registry maintained by the National Library of Medicine. NCT01815437 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.